The premise of this hypothesis is that the receptors for CCL8, especially CCR2 and CCR5, are overexpressed in breast cancers, and thus, their presence sensitizes cells against specific receptor‐targeting moieties [25, 26, 27, 28, 29]. This evidence concerns the gene CCR5 and breast carcinoma.